Updated Jul 16, 2026
McDonald Damien has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $200K.
Damien Mcdonald is the Chief Executive Officer of Enovis Corp, a medical technology company specializing in devices and services for patient care. He has been involved in the company as it focuses on injury prevention, joint replacement, and rehabilitation solutions.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-15 | ENOV | Enovis CORP | F — Tax withholding / forfeiture | 12.6K | $25.99 | $328K |
| 2026-03-11 | ENOV | Enovis CORP | A — Grant or award | 143.9K | $0.00 | |
| 2025-09-11 | ENOV | Enovis CORP | P — Open-market purchase | 6.5K | $30.97 | $200K |
Damien Mcdonald is the Chief Executive Officer of Enovis Corp, a medical technology company specializing in devices and services for patient care. He has been involved in the company as it focuses on injury prevention, joint replacement, and rehabilitation solutions.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($200K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live McDonald Damien profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.